PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 83 filers reported holding PRINCIPIA BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,482,000 | -7.2% | 74,955 | -7.9% | 0.00% | 0.0% |
| Q1 2020 | $4,832,000 | -41.4% | 81,369 | -46.0% | 0.00% | -50.0% |
| Q4 2019 | $8,250,000 | +109.8% | 150,591 | +8.1% | 0.00% | +100.0% |
| Q3 2019 | $3,933,000 | -11.4% | 139,266 | +4.2% | 0.00% | 0.0% |
| Q2 2019 | $4,438,000 | -10.5% | 133,679 | -8.4% | 0.00% | 0.0% |
| Q1 2019 | $4,961,000 | +21.1% | 145,876 | -2.5% | 0.00% | 0.0% |
| Q4 2018 | $4,096,000 | +826.7% | 149,549 | +887.1% | 0.00% | – |
| Q3 2018 | $442,000 | – | 15,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |